Navamedic ASA
OSE:NAVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Navamedic ASA
OSE:NAVA
|
NO |
|
G
|
Grow Solutions Holdings Inc
OTC:GRSO
|
CA |
|
M
|
Murata Manufacturing Co Ltd
SWB:MUR1
|
JP |
|
Checkit PLC
F:EKC1
|
UK |
|
C
|
Centerspace
F:WXC1
|
US |
|
F
|
Franklin Electric Co Inc
F:FE4
|
US |
|
Kelly Partners Group Holdings Ltd
ASX:KPG
|
AU |
|
Spero Therapeutics Inc
NASDAQ:SPRO
|
US |
|
Vcplus Ltd
SGX:43E
|
MY |
|
N
|
Nuix Ltd
OTC:NXLLF
|
AU |
|
4
|
4DMedical Ltd
OTC:FDMDF
|
AU |
|
C
|
Concord Biotech Ltd
BSE:543960
|
IN |
|
3
|
3M Co
SWB:MMM
|
US |
|
Peninsula Energy Ltd
ASX:PEN
|
AU |
|
Energy Services Of America Corp
NASDAQ:ESOA
|
US |
|
Pila Pharma AB
F:5KC
|
SE |
Wall St Price Targets
NAVA Price Targets Summary
Navamedic ASA
According to Wall Street analysts, the average 1-year price target for NAVA is 26.52 NOK with a low forecast of 26.26 NOK and a high forecast of 27.3 NOK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NAVA's stock price target?
Price Target
26.52
NOK
According to Wall Street analysts, the average 1-year price target for NAVA is 26.52 NOK with a low forecast of 26.26 NOK and a high forecast of 27.3 NOK.
What is the Revenue forecast for Navamedic ASA?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Navamedic ASA?
Projected CAGR
61%
The compound annual growth rate for Operating Income over the next 3 years is 61%.
